DK3023106T3 - Mycobacterium-antigensammensætning - Google Patents

Mycobacterium-antigensammensætning

Info

Publication number: DK3023106T3
Authority: DK; Denmark
Prior art keywords: antigenic composition; mycobacterium; mycobacterium antigenic; composition; antigenic
Prior art date: 2010-12-14

Application number

DK15201196.1T

Other languages

English (en)

Inventor

Stephane Andre Georges Godart

Amina Laanan

Dominique Ingrid Lemoine

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-14

Filing date

2011-12-14

Publication date

2019-09-30

2011-12-14 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2019-09-30 Application granted granted Critical

2019-09-30 Publication of DK3023106T3 publication Critical patent/DK3023106T3/da

Links

241000186359 Mycobacterium Species 0.000 title 1
230000000890 antigenic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Microbiology (AREA)
Mycology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

DK15201196.1T 2010-12-14 2011-12-14 Mycobacterium-antigensammensætning DK3023106T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42272310P	2010-12-14	2010-12-14
EP11799673.6A EP2651437B1 (en)	2010-12-14	2011-12-14	Mycobacterium antigenic composition

Publications (1)

Publication Number	Publication Date
DK3023106T3 true DK3023106T3 (da)	2019-09-30

Family

ID=45346501

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK11794778.8T DK2651436T3 (da)	2010-12-14	2011-12-14	Mycobakterie antigen sammensætning.
DK11799673.6T DK2651437T3 (da)	2010-12-14	2011-12-14	Mycobakterie-antigen sammensætning
DK15201196.1T DK3023106T3 (da)	2010-12-14	2011-12-14	Mycobacterium-antigensammensætning

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK11794778.8T DK2651436T3 (da)	2010-12-14	2011-12-14	Mycobakterie antigen sammensætning.
DK11799673.6T DK2651437T3 (da)	2010-12-14	2011-12-14	Mycobakterie-antigen sammensætning

Country Status (33)

Country	Link
US (5)	US9730992B2 (da)
EP (4)	EP2651436B1 (da)
JP (2)	JP5951633B2 (da)
KR (3)	KR20190022897A (da)
CN (4)	CN106822882A (da)
AR (1)	AR084285A1 (da)
AU (2)	AU2011343367B2 (da)
BR (2)	BR112013014599A2 (da)
CA (2)	CA2819298A1 (da)
CO (2)	CO6751287A2 (da)
CY (1)	CY1122187T1 (da)
DK (3)	DK2651436T3 (da)
EA (2)	EA027920B1 (da)
ES (3)	ES2748651T3 (da)
HR (3)	HRP20160606T1 (da)
HU (3)	HUE027932T2 (da)
IL (2)	IL226450A0 (da)
LT (1)	LT3023106T (da)
ME (1)	ME02380B (da)
MX (2)	MX344280B (da)
MY (1)	MY161412A (da)
PH (2)	PH12013501204A1 (da)
PL (3)	PL2651437T3 (da)
PT (2)	PT3023106T (da)
RS (1)	RS54687B1 (da)
SG (2)	SG190731A1 (da)
SI (3)	SI2651437T1 (da)
SM (1)	SMT201600118B (da)
TW (1)	TW201305192A (da)
UA (2)	UA110806C2 (da)
UY (1)	UY33802A (da)
WO (2)	WO2012080370A1 (da)
ZA (2)	ZA201304014B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2457926T1 (sl)	2005-04-29	2015-01-30	Glaxosmithkline Biologicals S.A.	Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis
DK2651436T3 (da) *	2010-12-14	2016-06-20	Glaxosmithkline Biologicals Sa	Mycobakterie antigen sammensætning.
CN107296793A (zh) *	2011-01-04	2017-10-27	阿尔西维尔法尔玛公司	适于治疗或预防结核的脂质体制剂
BR112014017217B1 (pt)	2012-01-12	2023-01-17	Archivel Farma, S.L	Agente e composição farmacêutica
US9993427B2 (en)	2013-03-14	2018-06-12	Biorest Ltd.	Liposome formulation and manufacture
GB201405921D0 (en) *	2014-04-02	2014-05-14	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response
IL313845A (en)	2014-04-23	2024-08-01	Juno Therapeutics Inc	Methods for enriching or producing immune cell populations for adoptive therapy
GB201513176D0 (en)	2015-07-27	2015-09-09	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response
GB201522068D0 (en)	2015-12-15	2016-01-27	Glaxosmithkline Biolog Sa	Dried composition
EP3551222B1 (en)	2016-12-07	2024-08-07	GlaxoSmithKline Biologicals SA	Process for making a liposome composition comprising a saponin
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
GB201707700D0 (en)	2017-05-12	2017-06-28	Glaxosmithkline Biologicals Sa	Dried composition
GB2600654B (en)	2017-05-30	2022-11-02	Glaxosmithkline Biologicals Sa	Novel devices
WO2019106192A1 (en)	2017-12-01	2019-06-06	Glaxosmithkline Biologicals Sa	Saponin purification
RU2728976C2 (ru) *	2018-03-22	2020-08-03	Зули Холдингз, Лтд.	Липосомный состав и его получение
ES3038006T3 (en)	2018-07-31	2025-10-08	Glaxosmithkline Biologicals Sa	Antigen purification method
WO2020109365A1 (en)	2018-11-29	2020-06-04	Glaxosmithkline Biologicals Sa	Methods for manufacturing an adjuvant
JP7640473B2 (ja)	2019-06-05	2025-03-05	グラクソスミスクラインバイオロジカルズソシエテアノニム	サポニン精製
EP3777884A1 (en)	2019-08-15	2021-02-17	GlaxoSmithKline Biologicals S.A.	Immunogenic composition
EP4028051A1 (en)	2019-09-09	2022-07-20	GlaxoSmithKline Biologicals S.A.	Immunotherapeutic compositions
BR112022008761A2 (pt)	2019-11-22	2022-07-26	Glaxosmithkline Biologicals Sa	Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
BR112022020660A2 (pt)	2020-05-05	2022-11-29	Glaxosmithkline Biologicals Sa	Dispositivo de mistura microfluídica e métodos de uso
US20230234992A1 (en)	2020-06-05	2023-07-27	Glaxosmithkline Biologicals Sa	Modified betacoronavirus spike proteins
MX2023006769A (es)	2020-12-09	2023-08-18	Glaxosmithkline Biologicals Sa	Modificacion de saponinas.
CN114034860A (zh) *	2021-11-01	2022-02-11	宁夏大学	一种结核分枝杆菌mtb39a蛋白抗体间接elisa检测方法及其试剂盒
WO2023242187A1 (en)	2022-06-15	2023-12-21	Glaxosmithkline Biologicals Sa	Enzymatic modification of saponins
CN116120411B (zh) *	2022-12-07	2024-04-12	中国疾病预防控制中心传染病预防控制所	结核分枝杆菌蛋白抗原混合物、多抗原融合蛋白及编码基因和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4436727A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
US4866034A (en)	1982-05-26	1989-09-12	Ribi Immunochem Research Inc.	Refined detoxified endotoxin
US4877611A (en)	1986-04-15	1989-10-31	Ribi Immunochem Research Inc.	Vaccine containing tumor antigens and adjuvants
CA1331443C (en)	1987-05-29	1994-08-16	Charlotte A. Kensil	Saponin adjuvant
US5278302A (en)	1988-05-26	1994-01-11	University Patents, Inc.	Polynucleotide phosphorodithioates
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE69015222T2 (de)	1989-02-04	1995-05-04	Akzo Nv	Tocole als Impfstoffadjuvans.
SG48309A1 (en)	1993-03-23	1998-04-17	Smithkline Beecham Biolog	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
WO1995026204A1 (en)	1994-03-25	1995-10-05	Isis Pharmaceuticals, Inc.	Immune stimulation by phosphorothioate oligonucleotide analogs
WO1996002555A1 (en)	1994-07-15	1996-02-01	The University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
UA56132C2 (uk)	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
CZ300688B6 (cs)	1995-09-01	2009-07-15	Corixa Corporation	Polypeptid, farmaceutický prostredek a vakcína s jeho obsahem, zpusob prípravy a použití polypeptidu, molekula rekombinantní DNA a její použití, expresní vektor, hostitelská bunka, fúsní porotein a diagnostický kit
CN1154730C (zh)	1995-09-01	2004-06-23	科里克萨有限公司	用于结核病诊断的化合物和方法
US5666153A (en)	1995-10-03	1997-09-09	Virtual Shopping, Inc.	Retractable teleconferencing apparatus
GB9619613D0 (en)	1996-09-19	1996-10-30	Breed Automotive Tech	An inflatable restraint for a vehicle
EP0859366A1 (en)	1997-02-12	1998-08-19	STMicroelectronics S.r.l.	Associative memory device with optimized occupation, particularly for the recognition of words
IL132201A0 (en) *	1997-04-08	2001-03-19	Merck & Co Inc	Stabilized human papillomavirus formulations
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en)	1997-05-08	2001-10-16	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6764840B2 (en)	1997-05-08	2004-07-20	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
GB9727262D0 (en)	1997-12-24	1998-02-25	Smithkline Beecham Biolog	Vaccine
DE19803453A1 (de) *	1998-01-30	1999-08-12	Boehringer Ingelheim Int	Vakzine
KR100797876B1 (ko) *	1998-04-07	2008-01-24	코릭사 코포레이션	마이코박테리움 튜베르쿨로시스 항원의 융합 단백질 및이의 용도
WO1999052549A1 (en) *	1998-04-09	1999-10-21	Smithkline Beecham Biologicals S.A.	Adjuvant compositions
US20040006242A1 (en)	1999-02-01	2004-01-08	Hawkins Lynn D.	Immunomodulatory compounds and method of use thereof
US6551600B2 (en)	1999-02-01	2003-04-22	Eisai Co., Ltd.	Immunological adjuvant compounds compositions and methods of use thereof
AU779978B2 (en)	1999-10-07	2005-02-24	Corixa Corporation	Fusion proteins of mycobacterium tuberculosis
DE60139963D1 (de)	2000-06-20	2009-10-29	Corixa Corp	Fusionsproteine aus mycobakterium tuberculosis
DK1296715T4 (da)	2000-06-29	2016-03-07	Smithkline Beecham Biolog	Multivalent vaccinesammensætning.
US7026465B2 (en)	2002-02-15	2006-04-11	Corixa Corporation	Fusion proteins of Mycobacterium tuberculosis
GB0411411D0 (en)	2004-05-21	2004-06-23	Glaxosmithkline Biolog Sa	Vaccines
SI2457926T1 (sl)	2005-04-29	2015-01-30	Glaxosmithkline Biologicals S.A.	Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis
EP2087128A4 (en) *	2006-11-01	2009-11-04	Immport Therapeutics Inc	COMPOSITIONS AND METHODS FOR IMMUNOMINANT ANTIGENES
KR101238795B1 (ko)	2007-05-24	2013-03-07	글락소스미스클라인 바이오로지칼즈 에스.에이.	동결건조 항원 조성물
KR20210049186A (ko)	2007-11-30	2021-05-04	애브비 바이오테크놀로지 리미티드	단백질 제형 및 이의 제조방법
KR100955470B1 (ko) *	2008-01-09	2010-04-30	대한민국(관리부서 질병관리본부장)	탄저 방어 항원의 제조 방법
WO2009111874A1 (en)	2008-03-11	2009-09-17	The Royal Institution For The Advancement Of Learning/ Mcgiil University	Low-temperature wafer level processing for mems devices
GB0910046D0 (en)	2009-06-10	2009-07-22	Glaxosmithkline Biolog Sa	Novel compositions
GB0910045D0 (en)	2009-06-10	2009-07-22	Glaxosmithkline Biolog Sa	Novel compositions
GB201008512D0 (en)	2010-05-21	2010-07-07	Health Prot Agency	Mycobacterial antigen composition
IT1400834B1 (it)	2010-07-07	2013-07-02	Aero Sekur S P A	Metodo e sistema per l'atterraggio di emergenza di un veicolo, come un elicottero o simili.
DK2651436T3 (da)	2010-12-14	2016-06-20	Glaxosmithkline Biologicals Sa	Mycobakterie antigen sammensætning.
GB201400819D0 (en)	2014-01-17	2014-03-05	Sec Dep For Health The	Mycobacterial antigen composition

2011
- 2011-12-14 DK DK11794778.8T patent/DK2651436T3/da active
- 2011-12-14 UA UAA201306356A patent/UA110806C2/uk unknown
- 2011-12-14 EP EP11794778.8A patent/EP2651436B1/en active Active
- 2011-12-14 PL PL11799673T patent/PL2651437T3/pl unknown
- 2011-12-14 SI SI201130787A patent/SI2651437T1/sl unknown
- 2011-12-14 PT PT152011961T patent/PT3023106T/pt unknown
- 2011-12-14 EP EP15201196.1A patent/EP3023106B1/en active Active
- 2011-12-14 UY UY0001033802A patent/UY33802A/es not_active Application Discontinuation
- 2011-12-14 SG SG2013041793A patent/SG190731A1/en unknown
- 2011-12-14 EA EA201390631A patent/EA027920B1/ru not_active IP Right Cessation
- 2011-12-14 LT LT15201196T patent/LT3023106T/lt unknown
- 2011-12-14 AU AU2011343367A patent/AU2011343367B2/en not_active Ceased
- 2011-12-14 DK DK11799673.6T patent/DK2651437T3/da active
- 2011-12-14 US US13/993,386 patent/US9730992B2/en active Active
- 2011-12-14 HU HUE11799673A patent/HUE027932T2/en unknown
- 2011-12-14 EP EP19188906.2A patent/EP3593813A1/en not_active Withdrawn
- 2011-12-14 TW TW100146325A patent/TW201305192A/zh unknown
- 2011-12-14 KR KR1020197004934A patent/KR20190022897A/ko not_active Ceased
- 2011-12-14 MY MYPI2013700989A patent/MY161412A/en unknown
- 2011-12-14 ES ES15201196T patent/ES2748651T3/es active Active
- 2011-12-14 CA CA2819298A patent/CA2819298A1/en not_active Abandoned
- 2011-12-14 HU HUE15201196A patent/HUE045766T2/hu unknown
- 2011-12-14 CA CA2819297A patent/CA2819297A1/en not_active Abandoned
- 2011-12-14 EA EA201390630A patent/EA027504B1/ru not_active IP Right Cessation
- 2011-12-14 CN CN201610883668.4A patent/CN106822882A/zh active Pending
- 2011-12-14 MX MX2013006819A patent/MX344280B/es active IP Right Grant
- 2011-12-14 KR KR1020137018059A patent/KR20140029376A/ko not_active Withdrawn
- 2011-12-14 ES ES11794778.8T patent/ES2574403T3/es active Active
- 2011-12-14 HU HUE11794778A patent/HUE028452T2/en unknown
- 2011-12-14 ES ES11799673.6T patent/ES2567190T3/es active Active
- 2011-12-14 JP JP2013543775A patent/JP5951633B2/ja not_active Expired - Fee Related
- 2011-12-14 WO PCT/EP2011/072817 patent/WO2012080370A1/en not_active Ceased
- 2011-12-14 SI SI201131805T patent/SI3023106T1/sl unknown
- 2011-12-14 PH PH1/2013/501204A patent/PH12013501204A1/en unknown
- 2011-12-14 SI SI201130859A patent/SI2651436T1/sl unknown
- 2011-12-14 WO PCT/EP2011/072816 patent/WO2012080369A1/en not_active Ceased
- 2011-12-14 BR BR112013014599A patent/BR112013014599A2/pt not_active Application Discontinuation
- 2011-12-14 AR ARP110104678A patent/AR084285A1/es unknown
- 2011-12-14 PT PT117947788T patent/PT2651436E/pt unknown
- 2011-12-14 RS RS20160225A patent/RS54687B1/sr unknown
- 2011-12-14 KR KR1020137018060A patent/KR101951894B1/ko not_active Expired - Fee Related
- 2011-12-14 HR HRP20160606TT patent/HRP20160606T1/hr unknown
- 2011-12-14 AU AU2011343368A patent/AU2011343368C1/en not_active Ceased
- 2011-12-14 PH PH1/2013/501203A patent/PH12013501203A1/en unknown
- 2011-12-14 ME MEP-2016-60A patent/ME02380B/me unknown
- 2011-12-14 HR HRP20160362TT patent/HRP20160362T1/hr unknown
- 2011-12-14 BR BR112013014598A patent/BR112013014598A2/pt not_active Application Discontinuation
- 2011-12-14 PL PL15201196T patent/PL3023106T3/pl unknown
- 2011-12-14 JP JP2013543776A patent/JP5951634B2/ja not_active Expired - Fee Related
- 2011-12-14 UA UAA201306355A patent/UA110118C2/uk unknown
- 2011-12-14 US US13/993,736 patent/US9352030B2/en active Active
- 2011-12-14 SG SG2013041918A patent/SG190937A1/en unknown
- 2011-12-14 CN CN201710066847.3A patent/CN106822883A/zh active Pending
- 2011-12-14 MX MX2013006818A patent/MX344706B/es active IP Right Grant
- 2011-12-14 PL PL11794778.8T patent/PL2651436T3/pl unknown
- 2011-12-14 DK DK15201196.1T patent/DK3023106T3/da active
- 2011-12-14 EP EP11799673.6A patent/EP2651437B1/en active Active
- 2011-12-14 CN CN201180060489.6A patent/CN103260642B/zh not_active Expired - Fee Related
- 2011-12-14 CN CN201180060222.7A patent/CN103249431B/zh not_active Expired - Fee Related
2013
- 2013-05-20 IL IL226450A patent/IL226450A0/en unknown
- 2013-05-20 IL IL226448A patent/IL226448A/en active IP Right Grant
- 2013-05-31 ZA ZA2013/04014A patent/ZA201304014B/en unknown
- 2013-05-31 ZA ZA2013/04015A patent/ZA201304015B/en unknown
- 2013-06-19 CO CO13146289A patent/CO6751287A2/es unknown
- 2013-06-19 CO CO13146307A patent/CO6751288A2/es unknown
2016
- 2016-04-18 US US15/131,422 patent/US20160220656A1/en not_active Abandoned
- 2016-04-22 SM SM201600118T patent/SMT201600118B/it unknown
2017
- 2017-07-06 US US15/643,084 patent/US10441648B2/en active Active
2019
- 2019-02-08 US US16/270,887 patent/US20190183998A1/en not_active Abandoned
- 2019-10-11 HR HRP20191843TT patent/HRP20191843T1/hr unknown
- 2019-10-18 CY CY20191101093T patent/CY1122187T1/el unknown

Also Published As

Publication number	Publication date
EP2651437B1 (en)	2016-02-10
AU2011343367B2 (en)	2015-05-21
CA2819298A1 (en)	2012-06-21
EP3023106B1 (en)	2019-07-31
TW201305192A (zh)	2013-02-01
PL3023106T3 (pl)	2019-12-31
IL226448A (en)	2017-09-28
CN103260642A (zh)	2013-08-21
EP3023106A1 (en)	2016-05-25
US20130287809A1 (en)	2013-10-31
ZA201304015B (en)	2018-12-19
ES2748651T3 (es)	2020-03-17
US20180071378A1 (en)	2018-03-15
HRP20160606T1 (hr)	2016-07-01
EA201390630A1 (ru)	2013-12-30
KR20130124525A (ko)	2013-11-14
CN103249431A (zh)	2013-08-14
EA027504B1 (ru)	2017-08-31
AU2011343368C1 (en)	2015-12-24
US20190183998A1 (en)	2019-06-20
AR084285A1 (es)	2013-05-08
CN106822882A (zh)	2017-06-13
MX2013006818A (es)	2013-08-26
DK2651437T3 (da)	2016-05-02
EP2651436A1 (en)	2013-10-23
BR112013014599A2 (pt)	2016-09-27
KR101951894B1 (ko)	2019-02-26
MY161412A (en)	2017-04-14
CN103260642B (zh)	2018-03-16
MX2013006819A (es)	2013-08-26
EA027920B1 (ru)	2017-09-29
HUE027932T2 (en)	2016-11-28
US9352030B2 (en)	2016-05-31
EA201390631A1 (ru)	2014-11-28
EP2651436B1 (en)	2016-03-30
HUE028452T2 (en)	2016-12-28
PL2651437T3 (pl)	2016-07-29
UA110806C2 (uk)	2016-02-25
WO2012080369A1 (en)	2012-06-21
LT3023106T (lt)	2019-10-25
CA2819297A1 (en)	2012-06-21
PT3023106T (pt)	2019-11-04
SI2651436T1 (sl)	2016-07-29
ME02380B (me)	2016-06-20
US10441648B2 (en)	2019-10-15
SMT201600118B (it)	2016-07-01
US20160220656A1 (en)	2016-08-04
CY1122187T1 (el)	2020-11-25
CN103249431B (zh)	2016-11-02
MX344280B (es)	2016-12-09
BR112013014598A2 (pt)	2017-09-19
JP2013545783A (ja)	2013-12-26
KR20140029376A (ko)	2014-03-10
SG190731A1 (en)	2013-07-31
IL226450A0 (en)	2013-07-31
PL2651436T3 (pl)	2016-10-31
SI3023106T1 (sl)	2019-11-29
HRP20160362T1 (hr)	2016-05-06
HUE045766T2 (hu)	2020-01-28
IL226448A0 (en)	2013-07-31
UA110118C2 (uk)	2015-11-25
AU2011343367A1 (en)	2013-07-11
EP3593813A1 (en)	2020-01-15
ES2567190T3 (es)	2016-04-20
SI2651437T1 (sl)	2016-05-31
JP5951633B2 (ja)	2016-07-13
PH12013501204A1 (en)	2013-07-29
RS54687B1 (sr)	2016-08-31
UY33802A (es)	2012-07-31
MX344706B (es)	2017-01-03
US20130280289A1 (en)	2013-10-24
DK2651436T3 (da)	2016-06-20
HRP20191843T1 (hr)	2019-12-27
PH12013501203A1 (en)	2013-07-29
JP5951634B2 (ja)	2016-07-13
PT2651436E (pt)	2016-06-08
AU2011343368B2 (en)	2015-08-20
JP2014505036A (ja)	2014-02-27
AU2011343368A1 (en)	2013-07-11
CO6751288A2 (es)	2013-09-16
WO2012080370A1 (en)	2012-06-21
EP2651437A1 (en)	2013-10-23
ZA201304014B (en)	2017-04-26
US9730992B2 (en)	2017-08-15
KR20190022897A (ko)	2019-03-06
ES2574403T3 (es)	2016-06-17
CN106822883A (zh)	2017-06-13
CO6751287A2 (es)	2013-09-16
SG190937A1 (en)	2013-07-31

Publication	Publication Date	Title
SMT201600118B (it)	2016-07-01	Composizione antigenica di mycobacterium
BR112012031667A2 (pt)	2016-11-08	composição
DK2640893T4 (da)	2021-05-10	Sammensætninger
LT3246021T (lt)	2020-02-10	Apiksabano kompozicijos
BR112012032683A2 (pt)	2016-11-29	composição
SMT201600458B (it)	2017-03-08	Composizioni comprendenti buprenorfina
SMT201700110B (it)	2017-03-08	Composizione immunogena
FI20106131A0 (fi)	2010-10-29	Insertteri
LT2865271T (lt)	2018-12-27	Pagerinta kompozicija
EP2636704A4 (en)	2014-05-07	FILM FORMING COMPOSITION
BR112012032980A2 (pt)	2016-11-22	composição
EP2628769A4 (en)	2014-05-21	FILM FORMING COMPOSITION
EP2548563A4 (en)	2013-09-04	ANTIALLERGIC COMPOSITION
SI2635269T1 (sl)	2019-10-30	Kombinacijski sestavek
EP2531219A4 (en)	2015-01-14	Carrier composition
DK2553004T3 (da)	2019-09-16	Sammensatte materialer
EP2609931A4 (en)	2014-06-04	IMMUNOGENIC COMPOSITION
BR112013014819A2 (pt)	2016-09-27	composição extratora
BR112013000109A2 (pt)	2019-09-24	composições
EP2575743A4 (en)	2015-04-08	WELD-INHIBITING COMPOSITIONS
BR112013015813A2 (pt)	2018-05-29	composição.
FI9262U1 (fi)	2011-06-15	Koostumus